This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rours, G. I. J. G.
Right arrow Articles by Ossewaarde, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rours, G. I. J. G.
Right arrow Articles by Ossewaarde, J. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2005, p. 4684-4690, Vol. 43, No. 9
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.9.4684-4690.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Use of Pooled Urine Samples and Automated DNA Isolation To Achieve Improved Sensitivity and Cost-Effectiveness of Large-Scale Testing for Chlamydia trachomatis in Pregnant Women

G. I. J. G. Rours,1* R. P. Verkooyen,2 H. F. M. Willemse,2 E. A. E. van der Zwaan,2 A. van Belkum,2 R. de Groot,1 H. A. Verbrugh,2 and J. M. Ossewaarde2

Department of Paediatrics, Erasmus MC—Sophia Children's Hospital, Rotterdam, The Netherlands,1 Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands2

Received 21 March 2005/ Returned for modification 25 April 2005/ Accepted 9 June 2005

The success of large-scale screening for Chlamydia trachomatis depends on the availability of noninvasive samples, low costs, and high-quality testing. To evaluate C. trachomatis testing with pregnant women, first-void urine specimens from 750 consecutive asymptomatic pregnant women from the Rotterdam area (The Netherlands) were collected. Initially, we investigated the performance of three different DNA isolation methods with 350 of these urines and 70 pools of 5 of the same subset of urine samples. The routinely used COBAS AMPLICOR test was compared to the COBAS AMPLICOR test with prior DNA isolation by use of the MagNA Pure large-volume kit and the MagNA Pure bacterial DNA isolation kit. The latter combination provided the best DNA test for pooled urines, with a sensitivity twice that of the other methods. Next, using all 750 urines, the COBAS AMPLICOR performance for individual testing was compared to pooled testing with the standard COBAS AMPLICOR procedure and subsequently to pooled testing with COBAS AMPLICOR in combination with the MagNA Pure bacterial DNA isolation kit. The sensitivity of COBAS AMPLICOR was 65% on individual and 42% on pooled urines but improved to 92% on pooled urines with the MagNA Pure bacterial DNA isolation kit, making this combination the best screening method. The C. trachomatis prevalence in this population appeared to be 6.4%. Additionally, the cost of the combined MagNA Pure bacterial DNA isolation kit and COBAS AMPLICOR method on pooled urines was only 56% of the cost of the standard COBAS AMPLICOR test applied to individual urines. Costs per positive case detected in the combined method were 39% of standard costs.


* Corresponding author. Mailing address: Department of Paediatrics, Erasmus MC—Sophia Children's Hospital, Rotterdam, The Netherlands. Phone: 31 10 46 36104. Fax: 31 10 46 33875. E-mail: rours123{at}planet.nl.


Journal of Clinical Microbiology, September 2005, p. 4684-4690, Vol. 43, No. 9
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.9.4684-4690.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Rours, G I J G, Hammerschlag, M R, Van Doornum, G J J, Hop, W C J, de Groot, R, Willemse, H F M, Verbrugh, H A, Verkooyen, R P (2009). Chlamydia trachomatis respiratory infection in Dutch infants. Arch. Dis. Child. 94: 705-707 [Abstract] [Full Text]  
  • Hadad, R, Fredlund, H, Unemo, M (2009). Evaluation of the new COBAS TaqMan CT test v2.0 and impact on the proportion of new variant Chlamydia trachomatis by the introduction of diagnostics detecting new variant C trachomatis in Orebro county, Sweden. Sex. Transm. Infect. 85: 190-193 [Abstract] [Full Text]  
  • Rours, I. G.I.J.G., Hammerschlag, M. R., Ott, A., De Faber, T. J.T.H.N., Verbrugh, H. A., de Groot, R., Verkooyen, R. P. (2008). Chlamydia trachomatis as a Cause of Neonatal Conjunctivitis in Dutch Infants. Pediatrics 121: e321-e326 [Abstract] [Full Text]  
  • Schachter, J., Chow, J. M., Howard, H., Bolan, G., Moncada, J. (2006). Detection of Chlamydia trachomatis by Nucleic Acid Amplification Testing: Our Evaluation Suggests that CDC-Recommended Approaches for Confirmatory Testing Are Ill-Advised.. J. Clin. Microbiol. 44: 2512-2517 [Abstract] [Full Text]  
  • Gotz, H M, Veldhuijzen, I K, Ossewaarde, J M, de Zwart, O, Richardus, J H (2006). Chlamydia trachomatis infections in multi-ethnic urban youth: a pilot combining STI health education and outreach testing in Rotterdam, Netherlands.. Sex. Transm. Infect. 82: 148-152 [Abstract] [Full Text]